Cargando…
Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7
Transient receptor potential melastatin 7 (TRPM7), a Ca(2+)-permeable channel, has been demonstrated to be present in cancer cells and involved in their growth and proliferation. The present study used midazolam, a benzodiazepine class anesthesic, to pharmacologically intervene in the expression of...
Autores principales: | DOU, YUNLING, LI, YUAN, CHEN, JINGKAO, WU, SIHAN, XIAO, XIAO, XIE, SHANSHAN, TANG, LIPENG, YAN, MIN, WANG, YOUQIONG, LIN, JUN, ZHU, WENBO, YAN, GUANGMEI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576402/ https://www.ncbi.nlm.nih.gov/pubmed/23426784 http://dx.doi.org/10.3892/ol.2013.1129 |
Ejemplares similares
-
Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7)
por: Valinsky, William C., et al.
Publicado: (2016) -
Transient receptor potential melastatin 7 aggravates necrotizing enterocolitis by promoting an inflammatory response in children
por: Li, Qingxiang, et al.
Publicado: (2022) -
Inhibition of transient receptor potential melastatin 7 (TRPM7) protects against Schwann cell trans-dedifferentiation and proliferation during Wallerian degeneration
por: Kim, Young Hwa, et al.
Publicado: (2020) -
Role of transient receptor potential melastatin type 7 channel in gastric cancer
por: Kim, Byung Joo, et al.
Publicado: (2016) -
The Underlying Mechanism of Modulation of Transient Receptor Potential Melastatin 3 by protons
por: Hossain Saad, Md Zubayer, et al.
Publicado: (2021)